EFPIA - NEWSLETTER

EFPIA Newsletter 12 November 2020

Can the pharmaceutical industry be more transparent?

With COVID-19 dominating the attention of the world's media, there is more interest than ever in how the pharmaceutical industry works.

Today we’re asking Andy Powrie-Smith, Executive Director of Communications & Partnerships at EFPIA "Can the industry be more transparent?"

Statements

11 November 2020 EFPIA statement on Building a European Health Union: preparedness and resilience

EFPIA welcomes the proposals from the Commission to strengthen the resilience and preparedness of Europe against serious...

06 November 2020 Joint EU-UK pharmaceutical industry response to Specialised Committee outcome

We are pleased the UK Government and EU Commission have responded to the concerns raised by industry and removed the...

Blogs

06 November 2020 IMI Impact: transforming the lives of children

The Innovative Medicines Initiative is making a difference to children living with paediatric diseases

10 November 2020 Let’s talk about NETs: World NET Cancer Day

Early diagnosis is critical to improving outcomes, however for many living with neuroendocrine tumors (NETs), diagnosis...

10 November 2020 Let's talk about NETs

“If you don’t suspect it you can’t detect it” – awareness and education are the key

12 November 2020 Why we need increased healthcare spending in Central and Eastern Europe

Countries in Central and Eastern Europe initially weathered the effects of the COVID-19 pandemic, but their vulnerability...

Videos

EFPIA symposium at the 30th Alzheimer Europe Conference

It is time for European healthcare systems to prepare for Alzheimer’s breakthroughs

Orphan Medicines: how to sustain innovation in an area of high unmet need?

Watch our latest virtual event on orphan medicines.

Events

17 NOV 2020

POLITICO's Health Care Summit Virtual event

Join the many thought-provoking discussions on November 17-18, where you'll be able to debate the biggest EU health...

Learn more →

17 NOV 2020

Designing Tomorrow’s Healthcare Systems Virtual event

EU-Russia Healthcare conference, with the support of the World Health Organization

Learn more →

20 NOV 2020

From silo budgeting to financial integration: Where does the EU stand in diabetes... Online event

Lessons learned from an EFPIA/The Economist Intelligence Unit study

Learn more →

10 DEC 2020

34th International Conference of Alzheimer’s Disease International Virtual event

Hope in the Age of Dementia New science. New knowledge. New solutions.

Learn more →

Our latest publications

Alzheimer’s Disease Health System Readiness – The Time to Act is Now 21 September 2020 (Publications)

We are at a turning point in our fight against dementia and Alzheimer’s disease. Long-awaited new therapies are on the...

What we are reading

Europe needs to give EU Orphan Drugs regulation more time to show its effectiveness 12 November 2020 (Euractiv)

Valuing vaccines 12 November 2020 (ABPI)

The vaccine industry – meeting the challenges of COVID-19 05 November 2020 (Health Europa)

It is time for European health care systems to prepare for Alzheimer’s breakthroughs 21 September 2020 (Politico)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶